Stay updated on Avelumab Program Rollover Study Clinical Trial

Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab Program Rollover Study Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page continues to show a 403 Forbidden error instead of the clinical-trial record. The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T02:38:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice about updates to terminology appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T02:52:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T02:40:49.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:39:10.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study content. This indicates that access to the record is blocked.
    Difference
    0.5%
    Check dated 2026-09-27T02:47:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, indicating restricted access. Added elements include the 403 header and a Home link, signaling a site-access issue rather than an update to the study information.
    Difference
    17%
    Check dated 2026-09-20T01:54:56.000Z thumbnail image

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.